Recently, our group did some work which looked for markers of AIH (autoimmune hepatitis) and we found 2 proteins which upregulated expression in different ways. So we expect that the 2 proteins will be of value in our next study. While all other studies look for targets of autoantibodies, the specificity of these two potential biomarkers is not addressed. How can we understand the differences between the autoantibody and the protein's upregulation of expression, which is not detected by the autoantibody?